Clover, Chengda IPOs Add To $1.2bn Raised By Chinese Bioventures

 
• By Dexter Jie Yan
  
fund raising
Chinese biotechs keep tapping into domestic capital market • Source: Alamy

More from China

More from Focus On Asia